Hemorrhagic shock and encephalopathy syndrome
Newcastle syndrome is a rare disorder characterized by the acute onset of severe shock, encephalopathy, and other symptoms in previously healthy children, leading to death or extremely severe neurologic consequences. It occurs primarily in infants between 3 and 8 months of age (mean age is 5 months), but has also been reported in children as young as 15 years of age.
-
Site of disease:
Whole body brain -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Coma rupture of liver capsule hematoma watery stool convulsion seizure -
Concurrent disease:
Related Drugs
Human serum albumin
Indication: 1. Shock caused by blood loss, trauma, and burns. 2. Increased intracranial pressure caused by cerebral edema and injury. 3. Edema or ascites caused by cirrhosis and kidney disease. 4. Prevention and treatment of hypoproteinemia. 5. Neonatal hyperbilirubinemia. 6. Used in cardiopulmonary bypass, auxiliary treatment of burns, auxiliary treatment of hemodialysis, and adult respiratory distress syndrome.
Manufacturer:
Nuoyi Biopharmaceutical Co., Ltd.
Human serum albumin
Indication: 1. Shock caused by blood loss, trauma, and burns. 2. Increased intracranial pressure caused by cerebral edema and injury. 3. Edema or ascites caused by cirrhosis and kidney disease. 4. Prevention and treatment of hypoproteinemia. 5. Neonatal hyperbilirubinemia. 6. Used in cardiopulmonary bypass, auxiliary treatment of burns, auxiliary treatment of hemodialysis, and adult respiratory distress syndrome.
Manufacturer:
Nuoyi Biopharmaceutical Co., Ltd.
Human serum albumin
Indication: 1. Shock caused by blood loss, trauma, and burns. 2. Increased intracranial pressure caused by cerebral edema and injury. 3. Edema or ascites caused by cirrhosis and kidney disease. 4. Prevention and treatment of hypoproteinemia. 5. Neonatal hyperbilirubinemia. 6. Used in cardiopulmonary bypass, auxiliary treatment of burns, auxiliary treatment of hemodialysis, and adult respiratory distress syndrome.
Manufacturer:
Nuoyi Biopharmaceutical Co., Ltd.
Aminobenzoic acid injection
Indication: This product is mainly used for bleeding caused by excessive primary fibrinolysis, including acute and chronic, localized, or systemic hyperfibrinolytic bleeding. The latter is common in cancer, leukemia, gynecological accidents, severe liver disease bleeding, etc.
Manufacturer:
Jiangsu Langou Pharmaceutical Co., Ltd.